Lowry–MacLean syndrome: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
Line 1: Line 1:
'''Lowry–MacLean syndrome''' is a rare genetic disorder characterized by intellectual disability, short stature, and distinctive facial features. The syndrome was first described by Lowry and MacLean in 1977.
== Lowry–MacLean Syndrome ==


==Etymology==
[[File:Autosomal_dominant_-_en.svg|thumb|right|Diagram of autosomal dominant inheritance]]
The syndrome is named after the two doctors who first described it, Dr. Robert Brian Lowry and Dr. J. Roger MacLean.


==Symptoms and Signs==
'''Lowry–MacLean Syndrome''' is a rare genetic disorder characterized by a combination of neurological, dermatological, and developmental abnormalities. It is inherited in an [[autosomal dominant]] pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Patients with Lowry–MacLean syndrome typically present with intellectual disability, short stature, and distinctive facial features. These facial features may include a broad forehead, deep-set eyes, a small nose with a broad bridge, and a thin upper lip. Other symptoms may include skeletal abnormalities, such as short fingers and toes, and heart defects.


==Causes==
== Clinical Features ==
Lowry–MacLean syndrome is a genetic disorder, which means it is caused by abnormalities in the genes. It is thought to be inherited in an autosomal recessive manner, which means both parents must carry a copy of the mutated gene for a child to be affected.


==Diagnosis==
Individuals with Lowry–MacLean Syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:
Diagnosis of Lowry–MacLean syndrome is based on the presence of characteristic clinical features. Genetic testing may also be used to confirm the diagnosis.


==Treatment==
* '''Neurological Abnormalities''': These may include [[seizures]], developmental delay, and intellectual disability. Some patients may also exhibit [[ataxia]] or other movement disorders.
There is currently no cure for Lowry–MacLean syndrome. Treatment is supportive and based on the symptoms present in each individual. This may include physical therapy, occupational therapy, and special education services for those with intellectual disability.


==Prognosis==
* '''Dermatological Manifestations''': Affected individuals often have distinctive skin findings, such as [[hypopigmentation]] or [[hyperpigmentation]], and may develop [[cutaneous]] lesions.
The prognosis for individuals with Lowry–MacLean syndrome varies. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications from the syndrome.
 
* '''Developmental Issues''': Delayed [[motor skills]] and [[speech development]] are frequently observed. Some children may also have [[learning disabilities]].
 
== Genetic Basis ==
 
Lowry–MacLean Syndrome is caused by mutations in a specific gene, which has yet to be fully identified. The disorder follows an autosomal dominant inheritance pattern, as depicted in the diagram. This means that an affected individual has a 50% chance of passing the mutated gene to their offspring.
 
== Diagnosis ==
 
Diagnosis of Lowry–MacLean Syndrome is primarily clinical, based on the characteristic symptoms and family history. Genetic testing can be used to confirm the diagnosis by identifying the specific mutation responsible for the disorder.
 
== Management ==
 
There is currently no cure for Lowry–MacLean Syndrome, and treatment is symptomatic and supportive. Management strategies may include:
 
* '''Neurological Care''': Anticonvulsant medications may be prescribed to control seizures. Physical and occupational therapy can help improve motor skills.
 
* '''Dermatological Treatment''': Skin lesions may be managed with topical treatments or other dermatological interventions.
 
* '''Developmental Support''': Early intervention programs, including speech and behavioral therapy, can assist in maximizing developmental potential.
 
== Prognosis ==
 
The prognosis for individuals with Lowry–MacLean Syndrome varies depending on the severity of symptoms. With appropriate management, many individuals can lead fulfilling lives, although they may require ongoing medical and supportive care.
 
== Related Pages ==


==See Also==
* [[Genetic disorder]]
* [[Genetic disorder]]
* [[Intellectual disability]]
* [[Autosomal dominant]]
* [[Short stature]]
* [[Neurological disorder]]
* [[Autosomal recessive inheritance]]
* [[Dermatology]]


==References==
{{Genetic disorders}}
<references />


[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
[[Category:Rare diseases]]
[[Category:Neurological disorders]]
[[Category:Syndromes]]
[[Category:Dermatology]]
{{stub}}

Revision as of 16:26, 16 February 2025

Lowry–MacLean Syndrome

Diagram of autosomal dominant inheritance

Lowry–MacLean Syndrome is a rare genetic disorder characterized by a combination of neurological, dermatological, and developmental abnormalities. It is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.

Clinical Features

Individuals with Lowry–MacLean Syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

  • Neurological Abnormalities: These may include seizures, developmental delay, and intellectual disability. Some patients may also exhibit ataxia or other movement disorders.

Genetic Basis

Lowry–MacLean Syndrome is caused by mutations in a specific gene, which has yet to be fully identified. The disorder follows an autosomal dominant inheritance pattern, as depicted in the diagram. This means that an affected individual has a 50% chance of passing the mutated gene to their offspring.

Diagnosis

Diagnosis of Lowry–MacLean Syndrome is primarily clinical, based on the characteristic symptoms and family history. Genetic testing can be used to confirm the diagnosis by identifying the specific mutation responsible for the disorder.

Management

There is currently no cure for Lowry–MacLean Syndrome, and treatment is symptomatic and supportive. Management strategies may include:

  • Neurological Care: Anticonvulsant medications may be prescribed to control seizures. Physical and occupational therapy can help improve motor skills.
  • Dermatological Treatment: Skin lesions may be managed with topical treatments or other dermatological interventions.
  • Developmental Support: Early intervention programs, including speech and behavioral therapy, can assist in maximizing developmental potential.

Prognosis

The prognosis for individuals with Lowry–MacLean Syndrome varies depending on the severity of symptoms. With appropriate management, many individuals can lead fulfilling lives, although they may require ongoing medical and supportive care.

Related Pages